Daxor ROE 2010-2011 | DXR

Current and historical return on equity (ROE) values for Daxor (DXR) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Daxor ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2011-12-31 $-0.01B $0.04B -14.46%
2011-09-30 $0.00B $0.04B -6.78%
2011-06-30 $0.00B $0.05B 8.56%
2011-03-31 $0.00B $0.05B 8.70%
2010-12-31 $0.01B $0.05B 10.81%
2010-09-30 $0.00B $0.05B 4.30%
2010-06-30 $0.00B $0.04B 4.26%
2010-03-31 $0.01B $0.05B 16.84%
2009-12-31 $0.01B $0.05B 13.71%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.055B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $20.039B 19.15
Encompass Health (EHC) United States $12.434B 24.84
DaVita (DVA) United States $9.726B 13.91
Elanco Animal Health (ELAN) United States $9.166B 20.50
Chemed (CHE) United States $6.585B 22.06
RadNet (RDNT) United States $5.522B 199.42
Option Care Health (OPCH) United States $4.666B 19.97
LifeStance Health (LFST) United States $2.131B 0.00
Addus HomeCare (ADUS) United States $2.126B 22.88
Astrana Health (ASTH) United States $1.756B 61.43
Aveanna Healthcare Holdings (AVAH) United States $1.638B 30.15
U.S Physical Therapy (USPH) United States $1.258B 31.47
Atai Life Sciences (ATAI) Germany $0.997B 0.00
Pennant (PNTG) United States $0.840B 29.62
MEDIROM Healthcare Technologies (MRM) Japan $0.054B 0.00
Psychemedics (PMD) United States $0.000B 0.00